Phase 2 Premenopausal Breast Cancer Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer

Breast CancerHER2-negative Breast CancerHormone Receptor Positive Tumor+1 more

SOLTI Breast Cancer Research Group96 enrolled15 locationsNCT05982093

Recruiting

Phase 2

Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients

Triple-Negative Breast CancerPremenopausal Breast Cancer

National Taiwan University Hospital124 enrolled1 locationNCT06225284

Recruiting

Phase 2

Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC

Metastatic Breast CancerER Positive Breast CancerPremenopausal Breast Cancer

National Taiwan University Hospital42 enrolled1 locationNCT05720260